Print

Purpose

The purpose of this clinical trial is to evaluate the short-term clinical outcomes of patients undergoing total shoulder arthroplasty who receive an extended postoperative course of oral tranexamic acid

Condition

Eligibility

Eligible Ages
Between 18 Years and 79 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Skeletally mature patients (ages 18-79) undergoing primary total shoulder arthroplasty

Exclusion Criteria

  • Patients with Cancer, venous thromboembolism, stroke, heart disease, pregnant or nursing, allergic to TXA, current tobacco use, anticoagulants other than aspirin.

Study Design

Phase
Phase 3
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Investigator)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
oral tranexamic acid
  • Drug: oral tranexamic acid
    one group of subjects will receive oral tranexamic acid and the other will receive oral placebo
Placebo Comparator
Oral Placebo
  • Drug: Placebo
    one group of randomized subjects will receive placebo and the other will receive oral tranexamic acid

Recruiting Locations

University of Alabama at Birmingham
Birmingham, Alabama 35205
Contact:
Walter Smith
205-930-8554
waltersmith@uabmc.edu

More Details

Status
Recruiting
Sponsor
University of Alabama at Birmingham

Study Contact

Walter Smith
205-930-8554
waltersmith@uabmc.edu

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.